General Surgery Coding Alert - 2003 Issue 38
Pharmaceuticals: DRUGMAKER PRICE-CHANGE RULES DELAYED TO 2004
Subscribe or sign in to view the full article.
Article Overview
This brief regulatory update explains that the Centers for Medicare & Medicaid Services postponed the effective date of a Medicaid drug rebate rule from October 2003 to January 2004. It is relevant to pharmaceutical manufacturers, compliance staff, and Medicaid reimbursement stakeholders who track federal pricing and recordkeeping obligations tied to the drug rebate program.
Why This Topic Matters
The change affects when pharmaceutical companies must comply with updated Medicaid pricing and documentation requirements, making timing and compliance planning important for manufacturers and their billing or regulatory teams.
What You Will Learn
- Why the effective date of the federal rule was changed
- What general compliance areas the regulation addresses
- Which stakeholders should monitor additional Medicaid drug rebate developments
- How the update relates to recordkeeping expectations for drug pricing and rebates
Who Should Read This
- Pharmaceutical manufacturers
- Regulatory compliance professionals
- Medicaid reimbursement stakeholders
- Health policy analysts
- Medical billing and coding professionals
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com